RDHL Hisse Senedi Fiyat Grafiği
RDHL Fiyat
Redhill Biopharma Ltd
$1.03
0.98%
$0.01
Kapanışta: May 15, 16:00:00 GMT-4
$1.03
0%
$0
Sonrası Piyasa: May 15, 20:00:00 GMT-4
Geri
Redhill Biopharma Ltd (RDHL) Fiyat
Önemli İstatistikler
Önceki Kapanış
$1.02
Açılış fiyatı
$1
Günün Aralığı
$0.98 - $1.03
52 haftalık aralık
$0.7101 - $3.3
İşlem hacmi
100.5K
Ort.Hacim
339.7K
Dividend yield
--
EPS (TTM)
-0.00
Piyasa Değeri
$5.2M
RDHL nedir?
RedHill Biopharma Ltd. engages in the development and commercialization of drugs for gastrointestinal (GI), infectious diseases, and oncology. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.
